Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN96331501
ISRCTN96331501
Completed
未知

Efficacy of modified electroconvulsive therapy in treatment-resistant schizophrenia

Wuhan Wudong Hospital0 sites108 target enrollmentMarch 11, 2024
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsTreatment-resistant schizophreniaMental and Behavioural Disorders

Overview

Phase
未知
Intervention
Not specified
Conditions
Treatment-resistant schizophrenia
Sponsor
Wuhan Wudong Hospital
Enrollment
108
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 11, 2024
End Date
March 1, 2020
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Wuhan Wudong Hospital

Eligibility Criteria

Inclusion Criteria

  • •1\. Aged \>18 years old
  • •2\. With complete medical records
  • •3\. With Positive and Negative Syndrome Scale (PANSS) scores for both positive and negative symptoms \>60 points
  • •4\. With a clinical diagnosis of TRS
  • •5\. Who had had TRS for \>5 years
  • •6\. Who had had previous treatment with 2 or more antipsychotic drugs of different chemical structure, each at a sufficient dosage, with no significant improvement after continuous treatment for more than 2 months
  • •7\. Those who did not show drug intolerance or maladaptation during the course of this study

Exclusion Criteria

  • •Does not meet inclusion criteria

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 2
Electroconvulsive therapy plus olanzapine on patients with bipolar mood disorderBipolar Mood disorder.Bipolar affective disorder- Manic episodeF30-F39
IRCT201107143930N8Vice chancellor for research, Shiraz University of Medical Sciences45
Completed
Phase 2
Comparing the effect of electroconvulsive therapy (ECT) with or without sodium valproate on cognitive impairments and treatment response in patients with bipolar disorder with manic episodeBipolar disorder.Bipolar affective disorder
IRCT201608049014N108Vice-chancellor for Research the Technology, Zahedan University of Medical Sciences40
Completed
Not Applicable
ketamine role in depression treatmentMajor Depression.
IRCT201104092266N2Isfahan University of Medical Sciences40
Completed
Not Applicable
A study to assess the effectiveness of shock therapy among patients of schizophrenia who are poorly responsive to antipsychotic medications.Health Condition 1: null- SchizophreniaHealth Condition 2: F20- Schizophrenia
CTRI/2011/08/001960Government Medical College and Hospital Chandigarh30
Recruiting
Not Applicable
ong-Term Effects of Electroconvulsive Therapy on Cognitive FunctioDepression, bipolar disorder, schizophrenia, schizoaffective disorder
JPRN-UMIN000047954Keio University50